GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
Clinical trial NCT07738341 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07738341
- Sponsor
- Eddingpharm (Zhuhai) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-08-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.